Revolutionary Weight Loss Drug Curbs Appetite and Burns Calories Without Side Effects
Researchers at the University of Copenhagen have identified a new drug target, NK2R, that could revolutionize weight loss treatments by reducing appetite and increasing energy expenditure without causing nausea or muscle loss. This discovery, published in Nature, shows promise for treating obesity and type 2 diabetes, conditions affecting over 380 million people globally. The drug candidate has shown positive results in both mice and non-human primates, potentially leading to more effective and tolerable therapies. The University holds patent rights, and related biotech companies have been established to further develop these treatments.







